---
title: "Baiyunshan Pharmaceutical's Unit Gets License to Produce Xuhanting Granules"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274600973.md"
description: "Baiyunshan Pharmaceutical's Unit Gets License to Produce Xuhanting Granules"
datetime: "2026-02-03T05:11:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274600973.md)
  - [en](https://longbridge.com/en/news/274600973.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274600973.md)
---

# Baiyunshan Pharmaceutical's Unit Gets License to Produce Xuhanting Granules



### Related Stocks

- [00874.HK](https://longbridge.com/en/quote/00874.HK.md)
- [600332.CN](https://longbridge.com/en/quote/600332.CN.md)

## Related News & Research

- [Baiyunshan Pharma Gets Approval for Carbocisteine Oral Solution's Registration in Macau](https://longbridge.com/en/news/281478355.md)
- [Baiyunshan Pharmaceutical Gets Nod for Marketing Transfer of Bone Health Drug](https://longbridge.com/en/news/281477935.md)
- [Enterprise Development Grants RMB100 Million Loan to Shenzhen-Listed Pharma Group](https://longbridge.com/en/news/282707739.md)
- [Asia Naphtha/Gasoline-Naphtha prices fall but supply uncertainty lingers](https://longbridge.com/en/news/282677307.md)
- [CICC Reaffirms Their Buy Rating on Livzon Pharmaceutical Group (LVZPF)](https://longbridge.com/en/news/282769048.md)